| Autor: |
Schmalzing M; Department of Medicine and Polyclinic II, University Hospital Würzburg, Oberdürrbacher Straße 6, 97080, Würzburg, Germany. Schmalzing_M@ukw.de., Sander O; Department of Rheumatology, University Hospital Düsseldorf, Düsseldorf, Germany., Seidl M; Institute of Pathology, University Hospital Düsseldorf, Düsseldorf, Germany., Marks R; Department of Internal Medicine I, University Hospital Freiburg, Freiburg, Germany., Blank N; University Hospital Heidelberg, Heidelberg, Germany., Kötter I; Department of Rheumatology and Immunology, Hospital Bad Bramstedt, Bad Bramstedt, Germany.; Rheumatology, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Tiemann M; Institute of HematoPathology Hamburg, Hamburg, Germany., Backhaus M; Dept. of Internal Medicine-Rheumatology and Clinical Immunology, Park-Klinik Weissensee (Berlin), Berlin, Germany., Manger B; Department of Medicine 3-Rheumatology and Immunology, University Hospital Erlangen, Erlangen, Germany., Hübel K; Department of Internal Medicine, University Hospital Cologne, Cologne, Germany., Müller-Ladner U; Department of Rheumatology and Clinical Immunology, Kerckhoff Klinik Bad Nauheim, Bad Nauheim, Germany., Henes J; Department of Medicine II, University Hospital Tübingen, Tübingen, Germany. |
| Abstrakt: |
Competing Interests: Declarations. Conflict of interest: M. Schmalzing, O. Sander, M. Seidl, R. Marks, N. Blank, I. Kötter, M. Tiemann, M. Backhaus, B. Manger, K. Hübel, U. Müller-Ladner, and J. Henes declare the following conflict of interest: consulting and lecturing activities for EUSA-Pharma. U. Müller-Ladner and M. Backhaus declare that there is no conflict of interest. For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case. The supplement containing this article is not sponsored by industry. |
Full text from SpringerLink